Company intelligence / Profile preview
Zura Bio
San Diego, California, United Stateszurabio.com ↗
- Ownership
- Public · ZURA
- Employees
- ~30
- Development stage
- Phase 2
01
Overview
Zura Bio develops novel dual-pathway monoclonal antibody therapies for serious immune system disorders. Its lead asset tibulizumab has entered a global Phase 2 trial for systemic sclerosis, while torudokimab and crebankitug have completed early clinical studies with promising safety profiles. The company’s approach aims to address unmet needs in complex autoimmune diseases by targeting multiple immune pathways simultaneously.
- Therapeutic areas
- ImmunologyDermatologyRheumatologyEndocrinology
- Modalities
- Monoclonal antibodies (mAbs)Bispecific antibodies
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
In‐licensed crebankitug from PfizerIn‐licensed torudokimab and tibulizumab from Eli LillySponsorship agreement with Benaroya Research Institute
04
Financials
- Market cap
- $542.4M
- Total revenue
- $0
- Enterprise value
- $337.3M
Beyond the preview
Go deeper on Zura Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zura Bio.